Overview

Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis

Status:
Completed

Trial end date:
1999-01-01

Target enrollment:

Participant gender:

Summary

OBJECTIVES: I. Determine the stability of uridine triphosphate (UTP) and examine the metabolism of exogenous nucleotides on airway epithelial surfaces in patients with cystic fibrosis. II. Determine the acute safety and efficacy of aerosolized UTP in children with cystic fibrosis.

Phase:

N/A

Details

Lead Sponsor:

FDA Office of Orphan Products Development

Collaborator:

University of North Carolina

Treatments:

Amiloride